Neurostimulation for Obstructive Sleep Apnea

Neurostimulation of hypoglossal nerve has emerged as an effective treatment option of obstructive sleep apnea (OSA). Since FDA approval in 2014, therapy has been widely used in select patients with moderate-to-severe OSA who do not benefit from positive airway pressure. Ongoing research and technolo...

Full description

Saved in:
Bibliographic Details
Published inOtolaryngologic clinics of North America Vol. 57; no. 3; pp. 457 - 465
Main Authors Suurna, Maria V., Klasner, Mia
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.06.2024
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Neurostimulation of hypoglossal nerve has emerged as an effective treatment option of obstructive sleep apnea (OSA). Since FDA approval in 2014, therapy has been widely used in select patients with moderate-to-severe OSA who do not benefit from positive airway pressure. Ongoing research and technological developments continue to advance the therapy to deliver personalized and efficient treatment to patients with OSA.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ISSN:0030-6665
1557-8259
DOI:10.1016/j.otc.2024.02.003